TreeWAS – Variant ID: rs2677780

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F10.1 Harmful use	0.086	0.914	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.081	0.919	0.000
F10.0 Acute intoxication	0.078	0.922	0.000
K70.9 Alcoholic liver disease, unspecified	0.066	0.934	0.000
F10.5 Psychotic disorder	0.064	0.936	0.000
F10.6 Amnesic syndrome	0.063	0.936	0.000
K70 Alcoholic liver disease	0.063	0.937	0.000
F10.2 Dependence syndrome	0.063	0.937	0.000
F10.8 Other mental and behavioural disorders	0.060	0.940	0.000
F10.7 Residual and late-onset psychotic disorder	0.060	0.940	0.000
F10.4 Withdrawal state with delirium	0.060	0.940	0.000
K70.3 Alcoholic cirrhosis of liver	0.059	0.941	0.000
F10.9 Unspecified mental and behavioural disorder	0.058	0.942	0.000
F10.3 Withdrawal state	0.058	0.942	0.000
K70.1 Alcoholic hepatitis	0.056	0.944	0.000
K70.4 Alcoholic hepatic failure	0.053	0.947	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.048	0.952	0.000
K70.0 Alcoholic fatty liver	0.046	0.954	0.000
Z50 Care involving use of rehabilitation procedures	0.043	0.957	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.042	0.958	0.000
Z50.8 Care involving use of rehabilitation procedures	0.041	0.959	0.000
Z50.5 Speech therapy	0.039	0.961	0.000
Z50.0 Cardiac rehabilitation	0.039	0.961	0.000
Z50.2 Alcohol rehabilitation	0.037	0.963	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.034	0.966	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.033	0.967	0.000
Z50.3 Drug rehabilitation	0.033	0.967	0.000
Z50.6 Orthoptic training	0.031	0.969	0.000
Z50.1 Other physical therapy	0.027	0.973	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.025	0.975	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.019	0.981	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.019	0.981	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.019	0.981	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.018	0.982	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.018	0.982	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.018	0.982	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.018	0.982	0.000
F11 Mental and behavioural disorders due to use of opioids	0.016	0.984	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.015	0.984	0.000
F13.3 Withdrawal state	0.014	0.986	0.000
F17.0 Acute intoxication	0.014	0.986	0.000
F17.1 Harmful use	0.014	0.986	0.000
F13.1 Harmful use	0.014	0.986	0.000
F12.2 Dependence syndrome	0.014	0.986	0.000
F17.2 Dependence syndrome	0.014	0.986	0.000
F13.9 Unspecified mental and behavioural disorder	0.014	0.986	0.000
F13.8 Other mental and behavioural disorders	0.014	0.986	0.000
F13.7 Residual and late-onset psychotic disorder	0.014	0.986	0.000
F13.6 Amnesic syndrome	0.014	0.986	0.000
F13.5 Psychotic disorder	0.014	0.986	0.000
F13.4 Withdrawal state with delirium	0.014	0.986	0.000
F13.0 Acute intoxication	0.014	0.986	0.000
F19.3 Withdrawal state	0.014	0.986	0.000
F19.1 Harmful use	0.014	0.986	0.000
F12.9 Unspecified mental and behavioural disorder	0.013	0.986	0.000
F12.8 Other mental and behavioural disorders	0.013	0.986	0.000
F12.7 Residual and late-onset psychotic disorder	0.013	0.986	0.000
F12.6 Amnesic syndrome	0.013	0.986	0.000
F12.4 Withdrawal state with delirium	0.013	0.986	0.000
F12.3 Withdrawal state	0.013	0.986	0.000
F17.8 Other mental and behavioural disorders	0.013	0.986	0.000
F17.7 Residual and late-onset psychotic disorder	0.013	0.986	0.000
F17.6 Amnesic syndrome	0.013	0.986	0.000
F17.5 Psychotic disorder	0.013	0.986	0.000
F17.4 Withdrawal state with delirium	0.013	0.986	0.000
F12.5 Psychotic disorder	0.013	0.986	0.000
F12.0 Acute intoxication	0.013	0.986	0.000
F16.9 Unspecified mental and behavioural disorder	0.013	0.986	0.000
F16.8 Other mental and behavioural disorders	0.013	0.986	0.000
F16.7 Residual and late-onset psychotic disorder	0.013	0.986	0.000
F16.6 Amnesic syndrome	0.013	0.986	0.000
F16.5 Psychotic disorder	0.013	0.986	0.000
F16.4 Withdrawal state with delirium	0.013	0.986	0.000
F16.3 Withdrawal state	0.013	0.986	0.000
F16.2 Dependence syndrome	0.013	0.986	0.000
F16.1 Harmful use	0.013	0.986	0.000
F16.0 Acute intoxication	0.013	0.986	0.000
F18.9 Unspecified mental and behavioural disorder	0.013	0.986	0.000
F18.8 Other mental and behavioural disorders	0.013	0.986	0.000
F18.7 Residual and late-onset psychotic disorder	0.013	0.986	0.000
F18.6 Amnesic syndrome	0.013	0.986	0.000
F18.5 Psychotic disorder	0.013	0.986	0.000
F18.4 Withdrawal state with delirium	0.013	0.986	0.000
F18.3 Withdrawal state	0.013	0.986	0.000
F18.2 Dependence syndrome	0.013	0.986	0.000
F18.1 Harmful use	0.013	0.986	0.000
F18.0 Acute intoxication	0.013	0.986	0.000
F12.1 Harmful use	0.013	0.986	0.000
F13.2 Dependence syndrome	0.013	0.987	0.000
F19.9 Unspecified mental and behavioural disorder	0.013	0.987	0.000
F19.8 Other mental and behavioural disorders	0.013	0.987	0.000
F19.7 Residual and late-onset psychotic disorder	0.013	0.987	0.000
F19.6 Amnesic syndrome	0.013	0.987	0.000
F19.4 Withdrawal state with delirium	0.013	0.987	0.000
F19.0 Acute intoxication	0.013	0.987	0.000
F14.1 Harmful use	0.013	0.987	0.000
F19.5 Psychotic disorder	0.013	0.987	0.000
F14.9 Unspecified mental and behavioural disorder	0.013	0.987	0.000
F14.8 Other mental and behavioural disorders	0.013	0.987	0.000
F14.7 Residual and late-onset psychotic disorder	0.013	0.987	0.000
F14.6 Amnesic syndrome	0.013	0.987	0.000
F14.5 Psychotic disorder	0.013	0.987	0.000
F14.4 Withdrawal state with delirium	0.013	0.987	0.000
F14.3 Withdrawal state	0.013	0.987	0.000
F14.0 Acute intoxication	0.013	0.987	0.000
F17.3 Withdrawal state	0.013	0.987	0.000
F14.2 Dependence syndrome	0.012	0.987	0.000
F11.3 Withdrawal state	0.012	0.988	0.000
F19.2 Dependence syndrome	0.012	0.988	0.000
F17.9 Unspecified mental and behavioural disorder	0.012	0.988	0.000
F11.0 Acute intoxication	0.012	0.988	0.000
F11.9 Unspecified mental and behavioural disorder	0.012	0.988	0.000
F11.8 Other mental and behavioural disorders	0.012	0.988	0.000
F11.7 Residual and late-onset psychotic disorder	0.012	0.988	0.000
F11.6 Amnesic syndrome	0.012	0.988	0.000
F11.5 Psychotic disorder	0.012	0.988	0.000
F11.4 Withdrawal state with delirium	0.012	0.988	0.000
F15.9 Unspecified mental and behavioural disorder	0.011	0.988	0.000
F15.8 Other mental and behavioural disorders	0.011	0.988	0.000
F15.7 Residual and late-onset psychotic disorder	0.011	0.988	0.000
F15.6 Amnesic syndrome	0.011	0.988	0.000
F15.5 Psychotic disorder	0.011	0.988	0.000
F15.4 Withdrawal state with delirium	0.011	0.988	0.000
F15.3 Withdrawal state	0.011	0.988	0.000
F15.2 Dependence syndrome	0.011	0.988	0.000
F11.1 Harmful use	0.011	0.989	0.000
F15.0 Acute intoxication	0.011	0.989	0.000
H53.8 Other visual disturbances	0.000	0.990	0.010
F11.2 Dependence syndrome	0.010	0.990	0.000
K70-K77 Diseases of liver	0.010	0.990	0.000
F15.1 Harmful use	0.009	0.990	0.000
I67.9 Cerebrovascular disease, unspecified	0.009	0.991	0.000
I67.1 Cerebral aneurysm, nonruptured	0.009	0.991	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.008	0.992	0.000
I60 Subarachnoid haemorrhage	0.008	0.992	0.000
I67 Other cerebrovascular diseases	0.008	0.992	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.008	0.992	0.000
K72 Hepatic failure, not elsewhere classified	0.008	0.992	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.992	0.008
G62.9 Polyneuropathy, unspecified	0.007	0.993	0.000
K71 Toxic liver disease	0.007	0.993	0.000
K77 Liver disorders in diseases classified elsewhere	0.007	0.993	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.007	0.993	0.000
K76.6 Portal hypertension	0.007	0.993	0.000
I60-I69 Cerebrovascular diseases	0.007	0.993	0.000
K72.9 Hepatic failure, unspecified	0.007	0.993	0.000
K76 Other diseases of liver	0.007	0.993	0.000
M19.0 Primary arthrosis of other joints	0.000	0.993	0.007
K75 Other inflammatory liver diseases	0.006	0.993	0.000
T81.0 Haemorrhage and haematoma complicating a procedure, not elsewhere classified	0.000	0.993	0.007
K73 Chronic hepatitis, not elsewhere classified	0.006	0.993	0.000
I67.4 Hypertensive encephalopathy	0.006	0.993	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.006	0.994	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.006	0.994	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.006	0.994	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.006	0.994	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.006	0.994	0.000
I60.8 Other subarachnoid haemorrhage	0.006	0.994	0.000
I67.5 Moyamoya disease	0.006	0.994	0.000
I67.3 Progressive vascular leukoencephalopathy	0.006	0.994	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.006	0.994	0.000
I67.2 Cerebral atherosclerosis	0.006	0.994	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.006	0.994	0.000
I07.1 Tricuspid insufficiency	0.000	0.994	0.006
K72.0 Acute and subacute hepatic failure	0.006	0.994	0.000
K75.0 Abscess of liver	0.006	0.994	0.000
K72.1 Chronic hepatic failure	0.006	0.994	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.994	0.006
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.006	0.994	0.000
I61 Intracerebral haemorrhage	0.006	0.994	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.006	0.994	0.000
M19.02 Primary arthrosis of other joints (Upper arm)	0.000	0.994	0.006
K76.7 Hepatorenal syndrome	0.006	0.994	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.006	0.994	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.994	0.006
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.006	0.994	0.000
G62 Other polyneuropathies	0.006	0.994	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.005	0.994	0.000
K71.8 Toxic liver disease with other disorders of liver	0.005	0.995	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.005	0.995	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.005	0.995	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.005	0.995	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.005	0.995	0.000
K71.2 Toxic liver disease with acute hepatitis	0.005	0.995	0.000
K71.9 Toxic liver disease, unspecified	0.005	0.995	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.005	0.995	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.005	0.995	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.005	0.995	0.000
K76.3 Infarction of liver	0.005	0.995	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.005	0.995	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.005	0.995	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.995	0.005
I69 Sequelae of cerebrovascular disease	0.005	0.995	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.995	0.005
I68 Cerebrovascular disorders in diseases classified elsewhere	0.005	0.995	0.000
K75.9 Inflammatory liver disease, unspecified	0.005	0.995	0.000
K76.5 Hepatic veno-occlusive disease	0.005	0.995	0.000
K76.4 Peliosis hepatis	0.005	0.995	0.000
K76.2 Central haemorrhagic necrosis of liver	0.005	0.995	0.000
M19.08 Primary arthrosis of other joints (Other)	0.000	0.995	0.005
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.995	0.005
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.995	0.005
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.005	0.995	0.000
K71.0 Toxic liver disease with cholestasis	0.005	0.995	0.000
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.995	0.005
K75.2 Nonspecific reactive hepatitis	0.005	0.995	0.000
K75.1 Phlebitis of portal vein	0.005	0.995	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.005	0.995	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.005	0.995	0.000
K76.1 Chronic passive congestion of liver	0.005	0.995	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.005	0.995	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.005	0.995	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.005	0.995	0.000
G62.1 Alcoholic polyneuropathy	0.005	0.995	0.000
G95.2 Cord compression, unspecified	0.005	0.995	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.005	0.995	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.005	0.995	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.004	0.995	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.005	0.995	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.005	0.995	0.000
K73.9 Chronic hepatitis, unspecified	0.004	0.995	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.995	0.000
K75.8 Other specified inflammatory liver diseases	0.004	0.995	0.000
G95 Other diseases of spinal cord	0.005	0.995	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.995	0.005
I61.8 Other intracerebral haemorrhage	0.004	0.996	0.000
G62.2 Polyneuropathy due to other toxic agents	0.004	0.996	0.000
G62.0 Drug-induced polyneuropathy	0.004	0.996	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.004	0.996	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.004	0.996	0.000
S82.60 Fracture of lateral malleolus (closed)	0.000	0.996	0.004
G62.8 Other specified polyneuropathies	0.004	0.996	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.004	0.996	0.000
K76.9 Liver disease, unspecified	0.004	0.996	0.000
K22.8 Other specified diseases of oesophagus	0.004	0.996	0.000
G95.8 Other specified diseases of spinal cord	0.004	0.996	0.000
G95.0 Syringomyelia and syringobulbia	0.004	0.996	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.004	0.996	0.000
I62 Other nontraumatic intracranial haemorrhage	0.004	0.996	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.004	0.996	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.004	0.996	0.000
I07 Rheumatic tricuspid valve diseases	0.000	0.996	0.004
I66.1 Occlusion and stenosis of anterior cerebral artery	0.004	0.996	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.004	0.996	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.004	0.996	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.004	0.996	0.000
I66.2 Occlusion and stenosis of posterior cerebral artery	0.004	0.996	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.004	0.996	0.000
I68.0 Cerebral amyloid angiopathy	0.004	0.996	0.000
I65.2 Occlusion and stenosis of carotid artery	0.004	0.996	0.000
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.004	0.996	0.000
T51.0 Ethanol	0.004	0.996	0.000
G82.5 Tetraplegia, unspecified	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
H53 Visual disturbances	0.000	0.996	0.004
I66.0 Occlusion and stenosis of middle cerebral artery	0.003	0.996	0.000
G82 Paraplegia and tetraplegia	0.004	0.996	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Y60.0 During surgical operation	0.000	0.996	0.004
G80-G83 Cerebral palsy and other paralytic syndromes	0.004	0.996	0.000
K74 Fibrosis and cirrhosis of liver	0.003	0.996	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.003	0.996	0.000
G80 Infantile cerebral palsy	0.004	0.996	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.003	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.003	0.996	0.000
G95.1 Vascular myelopathies	0.003	0.996	0.000
C09.9 Tonsil, unspecified	0.003	0.996	0.000
H53.2 Diplopia	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.003	0.997	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.003	0.997	0.000
G90-G99 Other disorders of the nervous system	0.003	0.997	0.000
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.003	0.997	0.000
G95.9 Disease of spinal cord, unspecified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
I67.8 Other specified cerebrovascular diseases	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
K76.8 Other specified diseases of liver	0.003	0.997	0.000
I65.1 Occlusion and stenosis of basilar artery	0.003	0.997	0.000
G60 Hereditary and idiopathic neuropathy	0.003	0.997	0.000
G64 Other disorders of peripheral nervous system	0.003	0.997	0.000
H53.4 Visual field defects	0.000	0.997	0.003
K75.4 Autoimmune hepatitis	0.002	0.997	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
I07.9 Tricuspid valve disease, unspecified	0.000	0.997	0.003
I07.8 Other tricuspid valve diseases	0.000	0.997	0.003
I07.2 Tricuspid stenosis with insufficiency	0.000	0.997	0.003
I07.0 Tricuspid stenosis	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
G83 Other paralytic syndromes	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
H53.5 Colour vision deficiencies	0.000	0.997	0.003
I62.1 Nontraumatic extradural haemorrhage	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
G80.0 Spastic cerebral palsy	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
Chapter VI Diseases of the nervous system	0.003	0.997	0.000
G82.0 Flaccid paraplegia	0.003	0.997	0.000
K22.7 Barrett's oesophagus	0.003	0.997	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
K74.1 Hepatic sclerosis	0.003	0.997	0.000
G80.1 Spastic diplegia	0.003	0.997	0.000
G82.4 Spastic tetraplegia	0.003	0.997	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.003	0.997	0.000
H53.6 Night blindness	0.000	0.997	0.003
H53.3 Other disorders of binocular vision	0.000	0.997	0.003
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.003	0.997	0.000
G82.3 Flaccid tetraplegia	0.003	0.997	0.000
G82.1 Spastic paraplegia	0.003	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.003	0.997	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
T51 Toxic effect of alcohol	0.003	0.997	0.000
G80.8 Other infantile cerebral palsy	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.003	0.997	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.003	0.997	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
G82.2 Paraplegia, unspecified	0.003	0.997	0.000
O20.0 Threatened abortion	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.997	0.003
N30.2 Other chronic cystitis	0.003	0.997	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.003	0.997	0.000
G80.4 Ataxic cerebral palsy	0.003	0.997	0.000
G80.3 Dyskinetic cerebral palsy	0.003	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
G92 Toxic encephalopathy	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.003	0.997	0.000
G80.2 Infantile hemiplegia	0.003	0.997	0.000
T51.9 Alcohol, unspecified	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
G61 Inflammatory polyneuropathy	0.002	0.997	0.000
G96 Other disorders of central nervous system	0.003	0.997	0.000
K22.1 Ulcer of oesophagus	0.003	0.997	0.000
K74.5 Biliary cirrhosis, unspecified	0.002	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
I63 Cerebral infarction	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.003	0.997	0.000
G83.1 Monoplegia of lower limb	0.003	0.997	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.003	0.997	0.000
G83.4 Cauda equina syndrome	0.003	0.997	0.000
G97.8 Other postprocedural disorders of nervous system	0.003	0.997	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.003	0.997	0.000
G81 Hemiplegia	0.003	0.997	0.000
G60.0 Hereditary motor and sensory neuropathy	0.002	0.997	0.000
O20 Haemorrhage in early pregnancy	0.003	0.997	0.000
G70-G73 Diseases of myoneural junction and muscle	0.003	0.997	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.002	0.997	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.003	0.997	0.000
T36.0 Penicillins	0.002	0.997	0.000
G60.3 Idiopathic progressive neuropathy	0.002	0.997	0.000
G60.2 Neuropathy in association with hereditary ataxia	0.002	0.997	0.000
G60.1 Refsum's disease	0.002	0.997	0.000
C09 Malignant neoplasm of tonsil	0.003	0.997	0.000
G83.3 Monoplegia, unspecified	0.002	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
G60.9 Hereditary and idiopathic neuropathy, unspecified	0.002	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
T45.5 Anticoagulants	0.002	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
T48.5 Anti-common-cold drugs	0.002	0.997	0.000
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.997	0.000
I08 Multiple valve diseases	0.000	0.997	0.003
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.000	0.997	0.002
G94.2 Hydrocephalus in other diseases classified elsewhere	0.002	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.002	0.997	0.000
G83.5 Locked-in syndrome	0.002	0.997	0.000
G83.2 Monoplegia of upper limb	0.002	0.997	0.000
G83.0 Diplegia of upper limbs	0.002	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.002	0.997	0.000
N21.0 Calculus in bladder	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.997	0.000
Y60.4 During endoscopic examination	0.000	0.997	0.002
K22 Other diseases of oesophagus	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
T38.7 Androgens and anabolic congeners	0.002	0.997	0.000
T38.4 Oral contraceptives	0.002	0.997	0.000
T38.2 Antithyroid drugs	0.002	0.997	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
K74.3 Primary biliary cirrhosis	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.002	0.998	0.000
G94.1 Hydrocephalus in neoplastic disease	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.002	0.998	0.000
D50.8 Other iron deficiency anaemias	0.000	0.998	0.002
K74.0 Hepatic fibrosis	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
A49.8 Other bacterial infections of unspecified site	0.000	0.998	0.002
G83.8 Other specified paralytic syndromes	0.002	0.998	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
G00 Bacterial meningitis, not elsewhere classified	0.002	0.998	0.000
G72 Other myopathies	0.002	0.998	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.002	0.998	0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.002	0.998	0.000
G97.2 Intracranial hypotension following ventricular shunting	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.002	0.998	0.000
G30-G32 Other degenerative diseases of the nervous system	0.002	0.998	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.002	0.998	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.002	0.998	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.002	0.998	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.002	0.998	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.002	0.998	0.000
G63.1 Polyneuropathy in neoplastic disease	0.002	0.998	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.002	0.998	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T51.8 Other alcohols	0.002	0.998	0.000
T51.3 Fusel oil	0.002	0.998	0.000
T51.2 2-Propanol	0.002	0.998	0.000
T51.1 Methanol	0.002	0.998	0.000
I05-I09 Chronic rheumatic heart diseases	0.000	0.998	0.002
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations